Comparison

Hematology app vs HemeOncBuddy

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

Hematology app

Features
Read full description

The HematologyApp is intended for use by medical professionals only. It offers a vast amount of hematology related content with risk calculators, diagnostic criteria, differential diagnostic lists, official guidelines, an extensive bone marrow and peripheral blood morphology atlas and a clinical study finder. Dr. JJWM Janssen, MD PhD and the Apps for Care and Science Foundation have used the highest standards to select and program the HematologyApp content in a way that will help hematologists to perform their everyday work in a more efficient way and to improve quality of patient care. As medicine is an ever-evolving science and standards and practices in medicine may rapidly change as new data become available, the individual medical professional should therefore consult a variety of sources. For this reason, please make sure to have the automatic app update option installed on your smartphone. Only the most current release of the HematologyApp should be consulted when information is sought; do not rely on older versions. Although we are doing our utmost best to keep the information in this App up-to-date, when prescribing medications according to the Hematology App, the user is advised to check the product information sheet accompanying each drug to verify conditions of use and identify any changes in dosage schedule or contraindications, particularly if the agent to be administered is new, infrequently used or has a narrow therapeutic range. The information provided in the HematologyApp may be changed without notice and is not guaranteed to be complete, error-free, correct or up-to date and is no substitute for individual patient assessment based upon the healthcare provider's examination of each patient and consideration of laboratory data and other factors unique to the patient. The HematologyApp should be used as a tool to help the user reach diagnostic and treatment decisions, bearing in mind that individual and unique circumstances may lead the user to reach decisions not presented in this App. Disclaimer for non-medical professional users: Please be sure to seek a doctor’s advice in addition to using this app and before making any medical decisions.

About

HemeOncBuddy

This app provides quick access to practice-changing clinical trials in Hematology and Oncology. It offers simplified summaries of trial background, inclusion/exclusion criteria, primary endpoints, and outcomes for easy reference.

Highlights
  • Practice-changing clinical trial summaries
  • Hematology and Oncology focus
  • Simplified trial information
  • Inclusion and exclusion criteria
  • Primary endpoints and outcomes
  • Quick reference tool
Features
Read full description

HemeOncBuddy is a free study hub built for hematology and oncology fellows and trainees - everything you need to keep up with the literature and prep for boards, in one fast, searchable app. WHAT'S INSIDE - 1,500+ pivotal clinical-trial summaries, each in the same structure (background, inclusion criteria, arms, primary/secondary endpoints, median follow-up, key results, notable toxicities) so you can scan them quickly. - A Question Bank with board-style questions, tutor and timed modes, explanations, and progress tracking. - ~2,000 active-recall flashcards across oncology, malignant and benign heme, and pharmacology — plus visual staging decks. - 120+ concise disease-site board-prep notes. - A conference & abstract-deadline tracker so you never miss a submission window. MADE FOR STUDYING - Full dark mode and adjustable text size. - Optional free account (Sign in with Apple, Google, or email) to sync your saved trials, Qbank progress, and notes across iPhone, iPad, and Mac. - No ads. No paywall. No login required to browse. HemeOncBuddy is an educational study aid only. It is not a substitute for medical advice, clinical judgment, or current guidelines, and must not be used to diagnose or treat patients. Always verify against primary literature and current guidelines.

Screenshots

Hematology app4 screens
HemeOncBuddy4 screens

Verdict

The call

The clearest difference is update cadence: Hematology app at monthly against HemeOncBuddy's every 24 months. On price, ads, in-app purchases and device support there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

UpkeepUpdate frequency

Hematology app ships an update monthly, HemeOncBuddy every 24 months. The most recent releases landed on November 11, 2026 and November 7, 2026 respectively.

Scorecard1 real difference · 9 level
Hematology app versus HemeOncBuddy: the parameters behind the verdict, then further details
ParameterHematology appHemeOncBuddy
PriceFreeFree
Rating—5.0 (19 ratings) — better
Positive reviews—100.0% of reviews
Number of ratings—19 — better
Update frequencyMonthly — betterEvery 24 months
AdsNoNo
In-app purchasesNoNo
Monetization—Free
DevicesiPhone, iPad, iPodiPhone, iPad, iPod
Requires iOS14.0 — better15.0
Further details — not scored
Size12 MB16 MB
Age rating12+17+
DeveloperStichting Apps for Care and ScienceVeli Bakalov

In-app purchases

None

Hematology app

No in-app purchases

None

HemeOncBuddy

No in-app purchases

Questions

Is Hematology app free?
Hematology app is free to download, with no in-app purchases.
Is HemeOncBuddy free?
HemeOncBuddy is free to download, with no in-app purchases.
Do Hematology app or HemeOncBuddy have ads?
Neither Hematology app nor HemeOncBuddy shows ads.
Which is updated more often, Hematology app or HemeOncBuddy?
Hematology app ships an update monthly, and HemeOncBuddy every 24 months. Most recently, Hematology app was updated on November 11, 2026 and HemeOncBuddy on November 7, 2026.

Other comparisons